簡易檢索 / 詳目顯示

研究生: 甘淑婷
Gan, Shu-Ting
論文名稱: 神經發展標記在精神分裂症與青少年危險行為之預測效度
Predictive validities of neurodevelopmental markers in schizophrenia and adolescents with risk behaviors
指導教授: 林聖翔
Lin, Sheng-Hsiang
學位類別: 碩士
Master
系所名稱: 醫學院 - 臨床醫學研究所
Institute of Clinical Medicine
論文出版年: 2014
畢業學年度: 102
語文別: 英文
論文頁數: 53
中文關鍵詞: 精神分裂症内表型細微體質特徵差異神經軟性功能神經發展標記青少年危險行為
外文關鍵詞: Schizophrenia, Endophenotype, Minor physical anomalies, Neurological soft sign, Neurodevelopment, Adolescent, Risk behavior
相關次數: 點閱:96下載:2
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 中文摘要
    目的
    神經發育假說認為精神分裂症的發生是源自於異常的腦部發育。而細微體質特徵 (Minor physical anomalies, MPAs) 與神經軟性功能 (Neurological soft signs, NSSs) 被認為是胚胎發育異常的生物標記。先前研究已經報導精神分裂症患者相較於健康對照組有較高的神經發展損傷。青少年危險行為是指對青少年的整體發展和適應狀態具有負面影響的行為,然而較少研究探討細微體質特徵與青少年危險行為之間的關聯。本研究的目的首先是找出細微體質特徵或神經軟性功能的項目中與精神分裂症以及青少年危險行為較為相關的項目,以及細微體質特徵與神經軟性功能在精神分裂症及青少年危險行為的預測效度。
    方法
    我們結合質性與量性項目改編細微體質特徵量表,測量個案的各部位特徵,及使用神經功能評估量表 (Neurological Evaluation Scale, NES) 作為神經軟性功能的測量工具。並且發展了一份自填式危險行為問卷,作為分類危險行為的標準,包含暴力、物質濫用、性行為、情緒問題。使用混合模型 (Mixed-effect model) 比較精神分裂症患者、其家屬及健康對照組之間的差異。利用羅吉斯迴歸分析 (Logistic regression model) 比較青少年危險行為組與其對照組的差異。並且使用Receiver operating characteristic (ROC) 曲線分析估計神經發展指標的預測效度。
    結果
    本研究共已收案210位精神分裂症病人,109位家屬,151位健康對照組,在個別使用細微體質特徵與神經軟性功能區分精神分裂症患者與健康對照組時,準確度分別為75.8%和80.6%,而在結合兩項神經發展標記時,準確度達83.8%。另外,青少年危險行為研究中已收案118位11-19歲青少年,ROC曲線分析的結果顯示,區分危險行為各組與其對照組的準確度,暴力行為為64.4%;物質濫用為65.3%;危險性行為為78.8%;情緒問題為68.6%。
    結論
    本篇研究顯示當同時使用細微體質特徵與神經軟性功能作為混合型的内表型可以更精準區分精神分裂症病人、其家屬及健康對照組。並且細微體質特徵與神經軟性功能在病人及其家屬都高於健康對照組,而危險行為青少年也有些微異常的細微體質特徵,可能符合精神分裂症及危險行為皆與神經發育異常有關的假說。

    關鍵字: 精神分裂症、内表型、細微體質特徵差異、神經軟性功能、神經發展標記、青少年、危險行為

    Background
    The neurodevelopmental hypothesis proposes that schizophrenia is originated from aberrant brain development. Minor physical anomalies (MPA) and neurological soft signs (NSS) are suggested as a biomarker associated with disruptions of fetal development. Numerous studies report an increased frequency of neurodevelopmental impairments in schizophrenic individuals compared with controls. Risk behaviors are those that can have negative effects on the overall development and well-being of youth. There were limited researches on the relationship between MPA and risk behaviors which may be derived from abnormal neurodevelopment. The aim of this study was to identify which specific MPA and NSS are more associated with schizophrenia and risk behaviors, and to determine the optimal predictive value of MPA and NSS scores in schizophrenia and adolescents with risk behaviors.
    Methods
    We developed a modified physical measurement scale composited of both qualitative and quantitative items and used Neurological Evaluation Scale (NES) to assess the NSS. A self-administered questionnaire for the assessment of risk behaviors was also developed. Group comparisons were conducted by using mixed-effect model among schizophrenia, their first-degree relatives, and stepwise logistic regression analysis between case and control of risk behavior. The ROC curve was conducted to evaluate predictive accuracy, sensitivity, and specificity of these neurodevelopmental markers.
    Results
    There were 210 patients with schizophrenia, 109 nonpsychotic first-degree relatives, 151 normal controls, and a total of 118 adolescents aged 11-19 were recruited in this study. The results of ROC curve analysis for schizophrenia were as follows: The analysis of MPA and NSS alone provided an accuracy of 75.8% and 80.6%, respectively, for schizophrenia vs. controls. The composite MPA and NSS provide a greater predictive validity in the model of patients with schizophrenia vs. controls provided an accuracy of 83.8%. The results of ROC curve analysis for risk behaviors were as follows: The model of violence vs. controls provided an accuracy of 64.4 %; the model substance abuse vs. controls provided an accuracy of 65.3%; the model of sex behavior vs. controls provided an accuracy of 78.8%; the model of emotion vs. controls provided an accuracy of 68.6%.
    Conclusion
    We found that subjects were most accurately classified when MPA & NSS were considered as a composite neurodevelopmental marker rather than independently. The MPA and NSS are more frequent in patients with schizophrenia, their relatives and MPA were slightly different in adolescents with risk behaviors compared to controls, which are consistent with the hypothesis of abnormal neurodevelopment in schizophrenia and adolescents with risk behaviors.

    中文摘要………………..………………..………………..I ABSTRACT………………………..………………...III 誌謝.………………...……………………………. …………………………………………....VI TABLE OF CONTENT……………...……………………………………………...VII CHAPTER I INTRODUCTION..………. ……………………………………………………………….………1 Section 1: Introduction of schizophrenia……………………………………………………………….1 Section 2: Neuodevelopmental model of schizophrenia…………………………………………1 Section 3: Concept of composite neurodevelopmental markers…………………………….3 Section 4: Introduction of risk behaviors in adolescents…………………………………………4 Section 5: Minor physical anomalies in adolescents with risk behaviors…………………5 Section 6: Hypothesis, Specific aims and significance…………………………………………….5 CHAPTER II METHODS AND MATERIALS…………………………………………………………………7 Section 1: Study subject of schizophrenia………………………………………………………………7 Section 2: Study subject of adolescents with risk behaviors…………………………………..8 Section 3: Assessment of minor physical anomalies………………………………………………9 Section 4: Assessment of neurological soft signs……………………………………………………9 Section 5: Statistical analysis………………………………………………………………………………10 CHAPTER III RESULTS…………………………………………………………………………………..………12 Section 1: Characteristic of schizophrenia, their first-degree relatives and controls…………………………………………………………………………………………………………..….12 Section 2: Minor physical anomalies in schizophrenia, their first-degree relatives and controls…………………………………………………………………………………………………..……12 Section 3: Neurological soft signs in schizophrenia, their first-degree relatives and controls………………………………………………………………………………………………………….13 Section 4: Predictive validity of composite neurodevelopmental markers in schizophrenia, their first-degree relatives and controls…………………………………..13 Section 5: Characteristic of adolescents with risk behaviors……………………….……14 Section 6: Minor physical anomalies in adolescents with risk behaviors………….15 Section 7: Predictive validity of minor physical anomalies in adolescents with risk behaviors………………………………………………………………………………………………………..15 CHAPTER IV DISCUSSIONS……………………………………………………………………………….17 Section 1: Contributions………………………………………………………………………………….17 Section 2: Minor physical anomalies in schizophrenia …………………………………….18 Section 3: Neurological soft signs in schizophrenia……………………………….…………20 Section 4: Composite neurodevelopmental markers of neurodevelopmental markers…………………………………………………………………………………………………………..21 Section 5: Minor physical anomalies in adolescents with risk behaviors………….22 Section 6: Predictive validities of neurodevelopmental markers in adolescent with risk behaviors…………………………………………………………………………………………………24 Section 7: Limitations……………………………………………………………………………………..25 CHAPTER V CONCLUSIONS AND SUGGESTIONS……………………………………………….27 Section 1: Conclusion………………………………………………………………………………………27 Section 2: Suggestions……………………………………………………………………………………..27 CHAPTER VI REFERENCES………………………………………………………………………………….28 LIST OF TABLES…………………………………………………………………………………………………VII Table 1. Characteristics of study subjects………………………………………………………….40 Table 2. Minor physical anomalies in schizophrenic patients, nonpsychotic first-degree relatives and normal controls………………………………………………………………..41 Table 3. Neurological soft signs in schizophrenic patients, nonpsychotic first-degree relatives and normal controls…………………………………………………………………………….42 Table 4. Stepwise logistic regression modeling for group comparison with MPAs.43 Table 5. Stepwise logistic regression modeling for group comparison with NSSs..44 Table 6. Stepwise logistic regression modeling for group comparison with MPAs & NSSs…………………………………………………………………………………………………………………..45 Table 7. The results of ROC curve analysis of MPAs, NSSs, and both MPAs & NSSs46 Table 8. Study subject of adolescent with risk behaviors…………………………………….47 Table 9. Minor physical anomalies in adolescent with risk behaviors………………….48 Table 10. Stepwise logistic regression modeling for group comparison in adolescent with risk behaviors ……………………………………………………………………...49 Table 11. The results of ROC curve analysis of minor physical anomalies in adolescent with risk behavior…………………………………………………….…50 LIST OF FIGURESVIII FIGURE LEGENDS…………………………………………………………………………..51 Figure 1. ROC curve analysis of composite neurodevelopmental marker in schizophrenic patients, nonpsychotic first-degree relatives and normal controls…………………………………………………………………………………………52 Figure 2. ROC curve analysis of minor physical anomalies in adolescents with risk behaviors………………………………………………………………………………………53

    Akabaliev, V., Sivkov, S., Mantarkov, M., & Ahmed-Popova, F. (2011). Biomarker profile of minor physical anomalies in schizophrenia patients. Folia medica, 53(3), 45-51.
    Aksoy-Poyraz, C., Poyraz, B. Ç., Turan, Ş., & Arıkan, M. K. (2011). Minor physical anomalies and neurological soft signs in patients with schizophrenia and their siblings. Psychiatry research, 190(1), 85-90.
    Angkustsiri, K., Krakowiak, P., Moghaddam, B., Wardinsky, T., Gardner, J., Kalamkarian, N., et al. (2011). Minor physical anomalies in children with autism spectrum disorders. Autism, 15(6), 746-760.
    Arseneault, L., Tremblay, R. E., Boulerice, B., & Sè, J. R. (2000). Minor physical anomalies and family adversity as risk factors for violent delinquency in adolescence. American Journal of Psychiatry, 157(6), 917-923.
    Association, A. P. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR®: American Psychiatric Pub.
    Bhutta, A. T., Cleves, M. A., Casey, P. H., Cradock, M. M., & Anand, K. (2002). Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. Jama, 288(6), 728-737.
    Bollini, A. M., Compton, M. T., Esterberg, M. L., Rutland, J., Chien, V. H., & Walker, E. F. (2007). Associations between schizotypal features and indicators of neurological and morphological abnormalities. Schizophrenia research, 92(1), 32-40.
    Buchanan, R., & Heinrichs, D. (1989). The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry research, 27(3), 335-350.
    Chan, R. C., Xu, T., Heinrichs, R. W., Yu, Y., & Gong, Q.-y. (2010a). Neurological soft signs in non-psychotic first-degree relatives of patients with schizophrenia: a systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 34(6), 889-896.
    Chan, R. C., Xu, T., Heinrichs, R. W., Yu, Y., & Wang, Y. (2010b). Neurological soft signs in schizophrenia: a meta-analysis. Schizophrenia bulletin, 36(6), 1089-1104.
    Chang, B. P., & Lenzenweger, M. F. (2004). Investigating graphesthesia task performance in the biological relatives of schizophrenia patients. Schizophrenia bulletin, 30(2), 327-334.
    Chen, Y. L. R., Chen, Y. H. E., & Mak, F. L. (2000). Soft neurological signs in schizophrenic patients and their nonpsychotic siblings. The Journal of nervous and mental disease, 188(2), 84-89.
    Compton, M., Bollini, A., McKenzie Mack, L., Kryda, A., Rutland, J., Weiss, P., et al. (2007). Neurological soft signs and minor physical anomalies in patients with schizophrenia and related disorders, their first-degree biological relatives, and non-psychiatric controls. Schizophrenia research, 94(1-3), 64-73.
    D'Onofrio, B. M., Van Hulle, C. A., Waldman, I. D., Rodgers, J. L., Harden, K. P., Rathouz, P. J., et al. (2008). Smoking during pregnancy and offspring externalizing problems: an exploration of genetic and environmental confounds. Dev Psychopathol, 20(1), 139-164.
    Donovan-Lepore, A.-M., Jaeger, J., Czobor, P., Abdelmessih, S., & Berns, S. M. (2006). Quantitative craniofacial anomalies in a racially mixed schizophrenia sample. Biological psychiatry, 59(4), 349-353.
    Egan, M., Goldberg, T., Gscheidle, T., & Weirich…, M. (2001). Relative risk for cognitive impairments in siblings of patients with schizophrenia. Biological ….
    Feinberg, I. (1982). Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? Journal of psychiatric research, 17(4), 319-334.
    Frakas, L. (1981). Anthropometry of the Head and Face in Medicine: Elsevier North Holland Inc, New York.
    Gourion, D., Goldberger, C., Olie, J., Lôo, H., & Krebs, M. (2004). Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophrenia research, 67(1), 23-31.
    Green, M., Nuechterlein, K., & Mintz, J. (1994). Backward masking in schizophrenia and mania. II. Specifying the visual channels. Archives of general psychiatry, 51(12), 945-951.
    Green, M. F., Satz, P., Gaier, D. J., Ganzell, S., & Kharabi, F. (1989). Minor physical anomalies in schizophrenia. Schizophrenia Bulletin, 15(1), 91.
    Guy, J. D., Majorski, L. V., Wallace, C. J., & Guy, M. P. (1983). The incidence of minor physical anomalies in adult male schizophrenics. Schizophrenia Bulletin, 9(4), 571-582.
    Hall, J. G., Froster-Iskenius, U. G., & Allanson, J. E. (1989). Handbook of normal physical measurements (Vol. 177): Oxford University Press New York.
    Hata, K., Iida, J., Iwasaka, H., Negoro, H., Ueda, F., & Kishimoto, T. (2003). Minor physical anomalies in childhood and adolescent onset schizophrenia. Psychiatry and clinical neurosciences, 57(1), 17-21.
    Hennessy, R. J., Lane, A., Kinsella, A., Larkin, C., O'Callaghan, E., & Waddington, J. L. (2004). 3D morphometrics of craniofacial dysmorphology reveals sex-specific asymmetries in schizophrenia. Schizophrenia research, 67(2), 261-268.
    Henriksson, K. M., Wickstrom, K., Maltesson, N., Ericsson, A., Karlsson, J., Lindgren, F., et al. (2006). A pilot study of facial, cranial and brain MRI morphometry in men with schizophrenia: Part 2. Psychiatry Research: Neuroimaging, 147(2), 187-195.
    Huang, C. J., Chiu, H. J., Lan, T. H., Wang, H. F., Kuo, S. W., Chen, S. F., ... & Loh, E. W. (2010). Significance of morphological features in schizophrenia of a Chinese population. Journal of psychiatric research, 44(2), 63-68.
    Ismail, B. T., Cantor-Graae, E., Cardenal, S., & McNeil, T. F. (1998a). Neurological abnormalities in schizophrenia: clinical, etiological and demographic correlates. Schizophrenia research, 30(3), 229-238.
    Ismail, B., Cantor-Graae, E., & McNeil, T. (1998b). Minor physical anomalies in schizophrenic patients and their siblings. The American journal of psychiatry, 155(12), 1695-1702.
    Ismail, B., Cantor-Graae, E., & McNeil, T. (2000). Minor physical anomalies in schizophrenia: cognitive, neurological and other clinical correlates. Journal of psychiatric research, 34(1), 45-56.
    Jaaro-Peled, H., Hayashi-Takagi, A., Seshadri, S., Kamiya, A., Brandon, N., & Sawa, A. (2009). Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends in neurosciences, 32(9), 485-495.
    Jablensky, A. (2000). Epidemiology of schizophrenia: the global burden of disease and disability. European archives of psychiatry and clinical neuroscience, 250(6), 274-285.
    John, J. P., Arunachalam, V., Ratnam, B., & Isaac, M. K. (2008). Expanding the schizophrenia phenotype: a composite evaluation of neurodevelopmental markers. Comprehensive psychiatry, 49(1), 78-86.
    King, K. M., & Chassin, L. (2007). A prospective study of the effects of age of initiation of alcohol and drug use on young adult substance dependence. Journal of Studies on Alcohol and Drugs, 68(2), 256.
    Lane, A., Colgan, K., Moynihan, F., Burke, T., Waddington, J., Larkin, C., et al. (1996). Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry research, 64(2), 105-114.
    Lane, A., Kinsella, A., Murphy, P., Byrne, M., Keenan, J., Colgan, K., et al. (1997). The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychological Medicine, 27(05), 1155-1164.
    Lawrie, S. M., Byrne, M., Miller, P., Hodges, A., Clafferty, R. A., Owens, D. G. C., et al. (2001). Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. The British Journal of Psychiatry, 178(6), 524-530.
    Lin, Y., Ma, X., Deng, W., Han, Y., Li, M., Liu, X., et al. (2012). Minor physical anomalies in patients with schizophrenia in a Chinese population. Psychiatry research, 200(2), 223-227.
    Lou, H. C., Henriksen, L., Bruhn, P., Børner, H., & Nielsen, J. B. (1989). Striatal dysfunction in attention deficit and hyperkinetic disorder. Archives of Neurology, 46(1), 48-52.
    Mahalik, J. R., Levine Coley, R., McPherran Lombardi, C., Doyle Lynch, A., Markowitz, A. J., & Jaffee, S. R. (2013). Changes in health risk behaviors for males and females from early adolescence through early adulthood. Health psychology, 32(6), 685.
    McCreadie, R., Thara, R., Srinivasan, T., & Padmavathi, R. (2003). Spontaneous dyskinesia in first-degree relatives of chronically ill, never-treated people with schizophrenia. The British journal of psychiatry : the journal of mental science, 183, 45-49.
    McGorry, P., McFarlane, C., Patton, G., Bell, R., Hibbert, M., Jackson, H., et al. (1995). The prevalence of prodromal features of schizophrenia in adolescence: a preliminary survey. Acta Psychiatrica Scandinavica, 92(4), 241-249.
    McGrath, J., Van Os, J., Hoyos, C., Jones, P., Harvey, I., & Murray, R. (1995). Minor physical anomalies in psychoses: associations with clinical and putative aetiological variables. Schizophrenia research, 18(1), 9-20.
    Mechri, A., Bourdel, M.-C., Slama, H., Gourion, D., Gaha, L., & Krebs, M.-O. (2009). Neurological soft signs in patients with schizophrenia and their unaffected siblings: frequency and correlates in two ethnic and socioeconomic distinct populations. European archives of psychiatry and clinical neuroscience, 259(4), 218-226.
    Mechri, A., Raffa, M., Mhalla, A., Gaha, L., Sfar, M., Kerkeni, A., et al. (2011). P. 3. b. 002 Impaired antioxidant defence systems in first-episode neuroleptic-nave patients with schizophrenia. European Neuropsychopharmacology, 21(3), 4.
    Miller, P., Byrne, M., Hodges, A., Lawrie, S., & Johnstone, E. (2002). Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the Edinburgh High Risk Study. Psychological medicine, 32(1), 173-180.
    Murray, R. M., O'Callaghan, E., Castle, D. J., & Lewis, S. W. (1992). A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull, 18(2), 319-332.
    Neelam, K., Garg, D., & Marshall, M. (2011). A systematic review and meta-analysis of neurological soft signs in relatives of people with schizophrenia. BMC psychiatry, 11(1), 139.
    O'Reilly, R., Lane, A., Cernovsky, Z. Z., & O'CALLAGHAN, E. (2001). Neurological soft signs, minor physical anomalies and handedness in schizophrenia. The European journal of psychiatry, 15(3), 189-192.
    Ozgen, H. M., Hop, J. W., Hox, J. J., Beemer, F. A., & van Engeland, H. (2010). Minor physical anomalies in autism: a meta-analysis. Mol Psychiatry, 15(3), 300-307.
    Picchioni, M., & Murray, R. (2007). Schizophrenia. BMJ (Clinical research ed.), 335(7610), 91-95.
    Pine, D. S., Shaffer, D., Schonfeld, I. S., & Davies, M. (1997). Minor physical anomalies: modifiers of environmental risks for psychiatric impairment? Journal of the American Academy of Child & Adolescent Psychiatry, 36(3), 395-403.
    Rossi, A., Pollice, R., Daneluzzo, E., Marinangeli, M., & Stratta, P. (2000). Behavioral neurodevelopment abnormalities and schizophrenic disorder: a retrospective evaluation with the Childhood Behavior Checklist (CBCL). Schizophrenia research, 44(2), 121-128.
    Schubert, E. W., & McNeil, T. F. (2004). Prospective study of neurological abnormalities in offspring of women with psychosis: birth to adulthood. American Journal of Psychiatry, 161(6), 1030-1037.
    Sturman, D. A., & Moghaddam, B. (2011). The neurobiology of adolescence: changes in brain architecture, functional dynamics, and behavioral tendencies. Neuroscience & Biobehavioral Reviews, 35(8), 1704-1712.
    Tenyi, T., Trixler, M., & Csábi, G. (2009). Minor physical anomalies in affective disorders. A review of the literature. Journal of affective disorders, 112(1), 11-18.
    Tikka, S. K., Nizamie, S. H., Das, B., Katshu, M. Z. U. H., & Goyal, N. (2013). Increased spontaneous gamma power and synchrony in schizophrenia patients having higher minor physical anomalies. Psychiatry research, 207(3), 164-172.
    Trixler, M., Tényi, T., Csábi, G., & Szabó, R. (2001). Minor physical anomalies in schizophrenia and bipolar affective disorder. Schizophrenia research, 52(3), 195-201.
    Waddington, J. L., Lane, A., Larkin, C., & O’Callaghan, E. (1999). The neurodevelopmental basis of schizophrenia: clinical clues from cerebro-craniofacial dysmorphogenesis, and the roots of a lifetime trajectory of disease. Biological psychiatry, 46(1), 31-39.
    Wakschlag, L. S., & Hans, S. L. (2002). Maternal smoking during pregnancy and conduct problems in high-risk youth: A developmental framework. Development and psychopathology, 14(02), 351-369.
    Weinberg, Jenkins, Marazita, & Maher. (2007). Minor physical anomalies in schizophrenia: a meta-analysis. Schizophrenia research, 89(1), 72-85.
    Weinberg, S., Jenkins, E., Marazita, M., & Maher, B. (2007). Minor physical anomalies in schizophrenia: a meta-analysis. Schizophrenia research, 89(1-3), 72-85.
    Weinberger, D. R. (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry, 44(7), 660-669.
    Xu, T., Chan, R., & Compton, M. (2011). Minor physical anomalies in patients with schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-analysis. PloS one, 6(9).
    Yazıcı, A. H., Demir, B., Yazıcı, K. M., & Göğüş, A. (2002). Neurological soft signs in schizophrenic patients and their nonpsychotic siblings. Schizophrenia research, 58(2), 241-246.
    Yeo, R. A., Gangestad, S. W., Edgar, C., & Thoma, R. (1999). The evolutionary genetic underpinnings of schizophrenia: the developmental instability model. Schizophrenia research, 39(3), 197-206.

    無法下載圖示 校內:2019-09-10公開
    校外:不公開
    電子論文尚未授權公開,紙本請查館藏目錄
    QR CODE